James E. Flynn - Sep 30, 2025 SCHEDULE 13G/A Report for Cullinan Therapeutics, Inc. Common Stock (CGEM)

Filing Manager
Flynn James E
Reporting Manager
Deerfield Mgmt, L.P.
Security
Cullinan Therapeutics, Inc. Common Stock
Symbol
CGEM
Shares outstanding
59.1M shares
Disclosed Ownership
2.93M shares
Ownership
4.95%
Form type
SCHEDULE 13G/A
Date filed
11/13/2025, 04:28 PM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Mgmt, L.P. 4.95% 2.93M 0 2.93M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Management Company, L.P. 4.95% 2.93M 0 2.93M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Partners, L.P. 4.95% 2.93M 0 2.93M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
James E. Flynn 4.95% 2.93M 0 2.93M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact